Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Recept Signal Transduct Res ; 38(1): 76-82, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29369009

ABSTRACT

INTRODUCTION/AIMS: In recent years, it has been shown that free fatty acids receptors (FFAR) of whose function in the cell surface plays a significant role in the regulation of cell function and nutrition as well are activated by various endogenous ligands, but mainly by fatty acids. Within FFAR of our interest are GPR 41, 43 and 120. The functions of these receptors are varied and dependent on the tissue where they are. The activation and signaling of these receptors, FFAR, are involved in many physiological processes, and currently the target of many drugs in metabolic disorders like obesity, diabetes and atherosclerosis. MATERIAL AND METHODS: Obesity was induced with hypercaloric diet (HD) in male Wistar rats for 20 weeks (n = 10). At the end, adipose tissue (abdominal and subcutaneous) was taken to perform assays for relative quantification mRNA expression by end-point RT-PCR and protein level expression by Western blot. RESULTS: These present data have shown for the first time that total mRNA isolation and protein expression from both adipose tissues (abdominal and subcutaneous) of rat in obesity condition yield significative statistical difference among the control versus obese groups, showing that the diet high in carbohydrates modifies the total presence of mRNA and protein level expression of the receptors GPR41, 43 and 120. CONCLUSIONS: Further comparative methods are in process to clarify whether or not the obesity changes the functional receptors in these two tissues for new pharmacological approaches.


Subject(s)
Obesity/drug therapy , Obesity/genetics , Receptors, G-Protein-Coupled/genetics , Adipose Tissue/metabolism , Animals , Atherosclerosis/drug therapy , Atherosclerosis/pathology , Diabetes Mellitus/drug therapy , Diabetes Mellitus/pathology , Diet, High-Fat , Disease Models, Animal , Fatty Acids, Nonesterified/genetics , Fatty Acids, Nonesterified/metabolism , Gene Expression Regulation/genetics , Humans , Insulin/genetics , Insulin/metabolism , Obesity/metabolism , Obesity/pathology , Rats , Receptors, G-Protein-Coupled/metabolism
2.
J Sci Food Agric ; 97(13): 4451-4458, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28276068

ABSTRACT

BACKGROUND: Obesity is associated with increased risk of a number of serious medical conditions, including urological disorders. This study investigated the effect of lipidic extracts of saladette tomato pomace (STP) and Serenoa repens (SR) on the prostate and bladder in a rat obese model induced by high-carbohydrate diet. RESULTS: High-sucrose-fed rats showed higher prostate weight as well as increased contractility and stromal and epithelial hyperplasia in the prostate. Treatment with STP and SR improved contractility and diminished hyperplasia and hypertrophy in the prostate. Obese animals also showed impaired bladder contractility, but neither extract reversed this deterioration. In the histological study, a disarray in the process of smooth muscle cell proliferation with non-parallel fibers was observed; interestingly, treatment with STP and SR led to improvement in this derangement. CONCLUSION: These findings indicated impaired contractility and hyperplasia in the prostate and bladder of obese rats induced by high sucrose. STP and SR could enhance prostate function by reducing contractility and hyperplasia and improve smooth muscle fiber structure and decrease cell proliferation in the bladder, suggesting their possible health-beneficial effects on lower urinary tract symptoms. © 2017 Society of Chemical Industry.


Subject(s)
Obesity/complications , Plant Extracts/administration & dosage , Prostate/drug effects , Serenoa/chemistry , Solanum lycopersicum/chemistry , Urinary Bladder/drug effects , Animals , Humans , Male , Obesity/metabolism , Prostate/physiopathology , Prostatic Diseases/drug therapy , Prostatic Diseases/etiology , Prostatic Diseases/metabolism , Prostatic Diseases/physiopathology , Rats , Rats, Wistar , Urinary Bladder/physiopathology , Urinary Bladder Diseases/drug therapy , Urinary Bladder Diseases/etiology , Urinary Bladder Diseases/metabolism , Urinary Bladder Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL